HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A J Richardson Selected Research

Schizophrenia (Dementia Praecox)

8/2007Niacin skin test response in dyslexia.
8/2007Negative correlation between cerebral inorganic phosphate and the volumetric niacin response in male patients with schizophrenia who have seriously and dangerously violently offended: a (31)P magnetic resonance spectroscopy study.
4/2004Cerebral metabolism in male patients with schizophrenia who have seriously and dangerously violently offended: a 31P magnetic resonance spectroscopy study.
12/2003Omega-3 and omega-6 fatty acid concentrations in red blood cell membranes relate to schizotypal traits in healthy adults.
7/2001The niacin skin flush test in schizophrenia: a replication study.
5/2000Red cell and plasma fatty acid changes accompanying symptom remission in a patient with schizophrenia treated with eicosapentaenoic acid.
1/2000Eicosapentaenoic acid treatment in schizophrenia associated with symptom remission, normalisation of blood fatty acids, reduced neuronal membrane phospholipid turnover and structural brain changes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A J Richardson Research Topics

Disease

7Dyslexia (Alexia)
08/2007 - 07/2000
7Schizophrenia (Dementia Praecox)
08/2007 - 01/2000
4Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
04/2004 - 07/2000
2Apraxias (Dyspraxia)
04/2004 - 07/2000
2Neurodevelopmental Disorders
07/2000 - 07/2000
1Hyperthermia
11/2023
1Heat Stress Disorders (Heat Cramp)
11/2023
1Overweight
04/2019
1Body Weight (Weight, Body)
04/2019
1Weight Loss (Weight Reduction)
04/2019
1Neoplasms (Cancer)
10/2016
1Bipolar Disorder (Manic Depressive Psychosis)
04/2008
1Dyspnea (Shortness of Breath)
02/2006
1Chest Pain (Chest Pains)
02/2006
1Embolism (Embolus)
02/2006
1Fetal Distress
02/2006
1Rupture
02/2006
1Autism Spectrum Disorder
04/2004
1Treatment-Resistant Depressive Disorder
10/2001
1Nervous System Diseases (Neurological Disorders)
03/2001
1Autistic Disorder (Autism)
07/2000
1Mental Disorders (Mental Disorder)
07/2000
1Atrophy
01/2000
1Confusion (Bewilderment)
01/2000
1Learning Disabilities (Learning Disability)
01/2000

Drug/Important Bio-Agent (IBA)

8Fatty Acids (Saturated Fatty Acids)IBA
04/2004 - 01/2000
7Phospholipids (Phosphatides)FDA LinkGeneric
08/2007 - 01/2000
4Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
04/2008 - 01/2000
3Niacin (Nicotinic Acid)FDA LinkGeneric
08/2007 - 07/2001
3Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
04/2004 - 07/2000
3Eicosapentaenoic AcidIBA
10/2001 - 01/2000
2Arachidonic Acid (Vitamin F)IBA
08/2007 - 07/2001
2Antipsychotic Agents (Antipsychotics)IBA
05/2000 - 01/2000
1Biomarkers (Surrogate Marker)IBA
11/2023
1CreatinineIBA
11/2023
1Hydrocortisone (Cortisol)FDA LinkGeneric
11/2023
1Proteins (Proteins, Gene)FDA Link
04/2019
1Dietary Carbohydrates (Carbohydrate, Dietary)IBA
04/2019
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
10/2016
1Phosphates (Orthophosphate)IBA
08/2007
1Oxygen (Dioxygen)IBA
02/2006
1Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA
12/2003
1methyl nicotinateIBA
07/2001
1SolutionsIBA
07/2001
1Platelet Activating FactorIBA
03/2001
1LipidsIBA
03/2001

Therapy/Procedure

1Reducing Diet
04/2019
1Cesarean Section (Caesarean Section)
02/2006
1Telescopes
01/2000